Clinical Trial Update: Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating atorvastatin (AtorVASTatin) for preventing vascular inflammatory occlusion in critically ill patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Renal Failure
• Stroke

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Alberta | Conditions: Myocardial Infarction, Stroke | Phase 2, Phase 3 | Status: COMPLETED